DEGEVMA Trademark

Trademark Overview


On Tuesday, October 18, 2022, a trademark application was filed for DEGEVMA with the United States Patent and Trademark Office. The USPTO has given the DEGEVMA trademark a serial number of 97636862. The federal status of this trademark filing is REVIVED - AWAITING FURTHER ACTION as of Monday, July 17, 2023. This trademark is owned by TEVA PHARMACEUTICALS USA, Inc.. The DEGEVMA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders (skin), musculoskeletal diseases and disorders, central and peripheral nervous system diseases and disorders, metabolic diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, urogenital diseases and disorders, and urinary diseases and disorders; pharmaceutical preparations for use in the treatment of oncological and metabolic diseases and disorders; pharmaceutical preparations for use in the treatment of cancer, drug dependence, fertility disorders, hormone replacement, infectious diseases, inflammatory conditions, menopause, ophthalmic disorders and diseases, pain, and psychological disorders; pharmaceutical preparations for use...
degevma

General Information


Serial Number97636862
Word MarkDEGEVMA
Filing DateTuesday, October 18, 2022
Status616 - REVIVED - AWAITING FURTHER ACTION
Status DateMonday, July 17, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesPharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders (skin), musculoskeletal diseases and disorders, central and peripheral nervous system diseases and disorders, metabolic diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, urogenital diseases and disorders, and urinary diseases and disorders; pharmaceutical preparations for use in the treatment of oncological and metabolic diseases and disorders; pharmaceutical preparations for use in the treatment of cancer, drug dependence, fertility disorders, hormone replacement, infectious diseases, inflammatory conditions, menopause, ophthalmic disorders and diseases, pain, and psychological disorders; pharmaceutical preparations for use in smoking cessation; contraceptive preparations

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, November 2, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameTEVA PHARMACEUTICALS USA, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressParsippany, NJ 07054

Trademark Events


Event DateEvent Description
Friday, October 21, 2022NEW APPLICATION ENTERED
Wednesday, November 2, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, March 28, 2023ASSIGNED TO EXAMINER
Tuesday, March 28, 2023PREVIOUS ALLOWANCE COUNT WITHDRAWN
Tuesday, March 28, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 29, 2023NON-FINAL ACTION WRITTEN
Wednesday, March 29, 2023NON-FINAL ACTION E-MAILED
Wednesday, March 29, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sunday, July 16, 2023ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Sunday, July 16, 2023ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Thursday, September 5, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, September 5, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, September 5, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, September 5, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, September 5, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, July 17, 2023TEAS PETITION TO REVIVE RECEIVED
Monday, July 17, 2023PETITION TO REVIVE-GRANTED
Tuesday, July 18, 2023NOTICE OF REVIVAL - E-MAILED